azithromycin (AZ) microsphere + test chloroquine (CQ) formulation + azithromycin (AZ) + chloroquine (CQ)
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Malaria Prophylaxis
Conditions
Malaria Prophylaxis
Trial Timeline
Apr 1, 2010 → Jun 1, 2010
NCT ID
NCT01100060About azithromycin (AZ) microsphere + test chloroquine (CQ) formulation + azithromycin (AZ) + chloroquine (CQ)
azithromycin (AZ) microsphere + test chloroquine (CQ) formulation + azithromycin (AZ) + chloroquine (CQ) is a phase 1 stage product being developed by Pfizer for Malaria Prophylaxis. The current trial status is completed. This product is registered under clinical trial identifier NCT01100060. Target conditions include Malaria Prophylaxis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01100060 | Phase 1 | Completed |
Competing Products
20 competing products in Malaria Prophylaxis